In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …

Background Targeted lung cancer screening is effective in reducing mortality by upwards of
twenty percent. However, screening is not universally available and uptake is variable and …

Rationale: Low uptake of low-dose computed tomography (LDCT) lung cancer screening,
particularly by current smokers of a low socioeconomic position, compromises effectiveness …

Lung cancer is the leading cause of cancer-related deaths worldwide, primarily because
most people present when the stage is too advanced to offer any reasonable chance of cure …

Although there is now strong evidence for the efficacy of low-radiation dose computed
tomography in reducing lung cancer mortality, the challenge is to establish screening …

Abstract Objectives This Liverpool Healthy Lung Programme is a response to high rates of
lung cancer and respiratory diseases locally and aims to diagnose lung cancer at an earlier …

Background Trials assessing the clinical utility of blood-based multi-cancer early detection
(MCED) tests are underway. Understanding public attitudes towards MCED screening is …

Background Lung cancer is the leading cause of cancer death worldwide. Routine UK lung
cancer screening is not yet available, thus understanding barriers to participation in lung …

Objective Understanding lung cancer screening behaviour is crucial to identifying potentially
modifiable factors for future intervention. Qualititative work has explored attitudes and beliefs …

Introduction Low uptake of low-dose computed tomography lung cancer screening by high-
risk groups compromises its effectiveness and equity as a population-level early detection …